Singapore markets close in 3 hours 57 minutes

Ensysce Biosciences, Inc. (ENSC)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.5920+0.0170 (+2.96%)
At close: 04:00PM EDT
0.6000 +0.01 (+1.35%)
After hours: 07:37PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 4.49M
Enterprise value 1.33M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)1.20
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.50

Trading information

Stock price history

Beta (5Y monthly) 0.80
52-week change 3-74.59%
S&P500 52-week change 323.33%
52-week high 32.6400
52-week low 30.5120
50-day moving average 30.6524
200-day moving average 31.0757

Share statistics

Avg vol (3-month) 3140.53k
Avg vol (10-day) 3185.83k
Shares outstanding 57.59M
Implied shares outstanding 67.59M
Float 87.15M
% held by insiders 15.55%
% held by institutions 12.31%
Shares short (30 Apr 2024) 49.64k
Short ratio (30 Apr 2024) 40.1
Short % of float (30 Apr 2024) 40.13%
Short % of shares outstanding (30 Apr 2024) 40.13%
Shares short (prior month 28 Mar 2024) 417.48k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:12
Last split date 331 Mar 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-612.72%

Management effectiveness

Return on assets (ttm)-155.91%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)2.23M
Revenue per share (ttm)0.99
Quarterly revenue growth (yoy)-64.10%
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-10.63M
Diluted EPS (ttm)-3.1600
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.12M
Total cash per share (mrq)0.15
Total debt (mrq)854.7k
Total debt/equity (mrq)N/A
Current ratio (mrq)0.69
Book value per share (mrq)-0.10

Cash flow statement

Operating cash flow (ttm)-10.78M
Levered free cash flow (ttm)-7.42M